Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03422679
Title	Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
Recruitment	Terminated
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Cellestia Biotech AG
Indications	osteosarcoma cholangiocarcinoma liposarcoma anaplastic large cell lymphoma breast cancer adenoid cystic carcinoma rhabdomyosarcoma desmoid tumor hematologic cancer Burkitt lymphoma colorectal cancer mantle cell lymphoma diffuse large B-cell lymphoma follicular lymphoma fibrosarcoma marginal zone lymphoma Advanced Solid Tumor peripheral T-cell lymphoma glomus tumor
Therapies	CB-103
Age Groups:	adult \| senior
Covered Countries	USA \| FRA \| ESP \| DEU \| CHE